DUBLIN--(BUSINESS WIRE)--The "Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0%.
The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period.
By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.
Based on component, the stable isotope-labeled compounds market is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest market share in 2018. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by growing drug research in the pharmaceutical industry and the increasing availability of deuterium-labeled compounds.
By application, the research segment dominated the stable isotope labeled compounds market in 2018.
Based on technology, the stable isotope-labeled compounds market is segmented into research, clinical diagnostics, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2018, owing to rising research activities in the biomedical, pharmaceutical, environmental & ecological, and agricultural sectors.
North America stable isotope labeled compounds market is expected to witness the highest growth during the forecast period.
The North America region market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing pharmaceutical and biopharmaceutical industry, support from the Isotope Production and Distribution Program Fund, and the presence of a large nuclear industry are driving market growth in the region.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the stable isotope labeled compounds market
- Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the stable isotope labeled compounds market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global stable isotope labeled compounds market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of the leading players in the stable isotope labeled compounds market
Key Topics Covered:
1.1 Objectives of the Study
1.2 Market Definition
2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.3 Primary Data
2.4 Market Size Estimation
2.5 Data Triangulation
3 Executive Summary
4 Premium Insights
4.1 Stable Isotope-Labeled Compounds: Market Overview
4.2 North America: Stable Isotope-Labeled Compounds, By Application (2018)
4.3 Geographical Snapshot of the Stable Isotope-Labeled Compounds Market
5 Market Overview
5.2 Market Dynamics
6 Stable Isotope-Labeled Compounds Market, By Type
6.6 Other Stable Isotopes
7 Stable Isotope-Labeled Compounds Market, By Application
7.3 Clinical Diagnostics
7.4 Industrial Applications
7.5 Other Applications
8 Stable Isotope-Labeled Compounds Market, By End User
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Research Institutes
8.4 Hospitals & Diagnostic Centers
8.5 Other End Users
9 Stable Isotope-Labeled Compounds Market, By Region
9.2 North America
9.4 Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (Overall Market) (2018)
10.4.1 Visionary Leaders
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies
11 Company Profiles
11.1 Cambridge Isotope Laboratories
11.2 Merck KGaA
11.3 URENCO Limited
11.5 Medical Isotopes
11.6 Omicron Biochemicals
11.7 Trace Sciences International
11.9 Taiyo Nippon Sanso Corporation
11.11 Rotem Industries Israel
11.12 Boc Sciences
11.15 Huayi Isotopes Co.
11.16 Mesbah Energy Co.
11.17 Shanghai Research Institute of Chemical Industry
11.18 13c Molecular
11.19 C/D/N Isotope
11.20 Shoko Co.
For more information about this report visit https://www.researchandmarkets.com/r/gx14u6